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Optimal hematocrit for maximal exercise performance in acute
and chronic erythropoietin-treated mice
Abstract
Erythropoietin (Epo) treatment increases hematocrit (Htc) and, consequently, arterial O(2) content. This
in turn improves exercise performance. However, because elevated blood viscosity associated with
increasing Htc levels may limit cardiac performance, it was suggested that the highest attainable Htc
may not necessarily be associated with the highest attainable exercise capacity. To test the proposed
hypothesis that an optimal Htc in acute and chronic Epo-treated mice exists-i.e., the Htc that facilitates
the greatest O(2) flux during maximal exercise-Htc levels of wild-type mice were acutely elevated by
administering novel erythropoiesis-stimulating protein (NESP; wtNESP). Furthermore, in the transgenic
mouse line tg6 that reaches Htc levels of up to 0.9 because of constitutive overexpression of human Epo,
the Htc was gradually reduced by application of the hemolysis-inducing compound phenylhydrazine
(PHZ; tg6PHZ). Maximal cardiovascular performance was measured by using telemetry in all
exercising mice. Highest maximal O(2) uptake ( $$\dot{\hbox{ V }}$$ O(2max)) and maximal time to
exhaustion at submaximal exercise intensities were reached at Htc values of 0.58 and 0.57 for wtNESP,
and 0.68 and 0.66 for tg6PHZ, respectively. Rate pressure product, and thus also maximal working
capacity of the heart, increased with elevated Htc values. Blood viscosity correlated with $$\dot{\hbox{
V }}$$ O(2max). Apart from the confirmation of the Htc hypothesis, we conclude that tg6PHZ adapted
better to varying Htc values than wtNESP because of the higher optimal Htc of tg6PHZ compared to
wtNESP. Of note, blood viscosity plays a critical role in limiting exercise capacity.
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Erythropoietin (Epo) treatment increases hematocrit (Htc) and,
consequently, arterial O2 content. This in turn improves exercise
performance. However, because elevated blood viscosity associated
with increasing Htc levels may limit cardiac performance, it was sug-
gested that the highest attainable Htc may not necessarily be asso-
ciated with the highest attainable exercise capacity. To test the
proposed hypothesis that an optimal Htc in acute and chronic Epo-
treated mice exists—i.e., the Htc that facilitates the greatest O2 ﬂux
during maximal exercise—Htc levels of wild-type mice were acutely
elevated by administering novel erythropoiesis-stimulating protein
(NESP; wtNESP). Furthermore, in the transgenic mouse line tg6 that
reaches Htc levels of up to 0.9 because of constitutive overexpres-
sion of human Epo, the Htc was gradually reduced by application of
the hemolysis-inducing compound phenylhydrazine (PHZ; tg6PHZ).
Maximal cardiovascular performance was measured by using tele-
metry in all exercising mice. Highest maximal O2 uptake ( _VO2max)
and maximal time to exhaustion at submaximal exercise intensities
were reached atHtc values of 0.58 and 0.57 forwtNESP, and 0.68 and
0.66 for tg6PHZ, respectively. Rate pressure product, and thus also
maximal working capacity of the heart, increased with elevated Htc
values. Blood viscosity correlated with _VO2max. Apart from the con-
ﬁrmation of the Htc hypothesis, we conclude that tg6PHZ adapted
better to varying Htc values than wtNESP because of the higher
optimal Htc of tg6PHZ compared towtNESP. Of note, blood viscosity
plays a critical role in limiting exercise capacity.
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In a normal physiological hematocrit (Htc) range, eryth-ropoietin (Epo) treatment or red blood cell retransfusion that
increases hemoglobin concentration ([Hb]) improves maximal
O2 uptake ( _VO2max) and enhances endurance performance
(1–6). Little, however, is known regarding the impact of [Hb]
alteration over a wide-ranging Htc. Augmented [Hb] values are
associated with a rise in blood viscosity and, consequently, with a
higher peripheral vascular resistance that may reduce _VO2max
because of the falling cardiac output (7, 8). Accordingly, the
exercise capacity of polycythemic patients with chronic ob-
structive pulmonary disease (COPD) is improved after hemodi-
lution (9). Because of these counteracting effects, it was
suggested that the optimal Htc may be lower than expected be-
cause of limitations induced by a higher blood viscosity (8, 10–
12). Although the role of Htc on exercise performance seems
obvious, there is only one ex vivo study available addressing the
above hypothesis in isolated higher vertebrate muscles (11). It
should be noted, however, that this may vary under different
circumstances because of the blood's non-Newtonian behavior
(13). Factors affecting this variation include the species, the or-
gans involved, and whether the organism is in resting or ex-
ercising conditions (11, 12, 14–16). Thus, the above mentioned
observations do not always reﬂect the general situation in ex-
ercising mammals and humans.
The optimal Htc hypothesis is in disagreement with several
studies (17, 18). All of these authors provide evidence that O2
delivery and thus exercise performance, including _VO2max, re-
mained relatively constant with chronic excessive erythrocytosis.
These ﬁndings indicate that adaptive mechanisms to excessive
erythrocytosis exist.
To explore the consequences of excessive erythrocytosis in
vivo we developed a transgenic mouse line (termed tg6) that
reaches Htc values of 0.8–0.9 as a result of a constitutive over-
expression of human Epo cDNA (19). Adaptive mechanisms to
excessive erythrocytosis include increased plasma nitric oxide
levels and enhanced erythrocyte ﬂexibility (19, 20). These data
suggest that a shift of the optimal Htc for a maximal endurance
performance to a higher Htc value occurs in tg6 mice.
The present study tested the hypothesis that there is an optimal
Htc value that allows for maximal systemic endurance perform-
ance. The effect of chronically elevated Htc on exercise capacity
may differ from that of acutely elevatedHtc.We propose that mice
with excessive erythrocytosis adapt better to varyingHtc levels than
animals that experience an acute increase in Htc level. For this
purpose, wild-type mice were injected with novel erythropoiesis
stimulating protein (NESP; wtNESP) to increase Htc, tg6 mice
were treated with the hemolysis-inducing compound phenyl-
hydrazine (PHZ; tg6PHZ), and both wild-type and tg6 mice that
did not receive treatment served as controls. Metabolic and car-
diovascular measurements were obtained at rest and during
endurance performance, whereas whole-blood analysis including
rheology was carried out at rest.
Results
Male wild-type and tg6 mice were approximately 8 and 9 weeks
old, respectively, when beginning their respective treatments. As
expected, differences in Htc were initially observed (Table S1):
whereas wild-type males had an Htc of 0.46 ± 0.03, the con-
stitutively Epo-overexpressing transgenic tg6 males suffered
from excessive erythrocytosis expressed Htc values of 0.78 ±
0.06. No differences in age, resting mean arterial blood pressure,
heart rate, O2 uptake ( _VO2), or respiratory exchange ratio (RER)
were observed between wild-type and tg6 animals at the beginning
of the incremental exercise test.
The Impact of Htc Manipulation. The results of wild-type/wtNESP
and tg6/tg6PHZ after approximately 4 and 3 weeks of treatment,
respectively, are depicted in Fig. S1 and Fig. S2. Both ﬁgures
show [Hb], arterial O2 saturation (SaO2), plasma, and blood
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volume in relation to the Htc level of each individual mouse used
in this study. As shown in Fig. S1 a, there was a linear increase in
[Hb] with greater Htc values in all wild-type and tg6 mice used.
Whereas SaO2 (Fig. S1 b) and plasma volume (Fig. S2 a) did not
signiﬁcantly change in any animal, irrespective of treatment and/
or genotype, changes in blood volumes paralleled those seen in
Htc levels (Fig. S2 b). As is deﬁned via the (degree two) poly-
nomial equation, alterations at lower Htc values had a lesser
impact on blood volume changes than those that were observed at
higher Htc levels. Indeed, the increment of blood volume at Htc
levels from 0.4 to 0.5 was approximately 19 mL/kg for wtNESP
and 10 mL/kg for tg6PHZ, whereas the increment between 0.6
and 0.7 was approximately 37 and 50 mL/kg, respectively.
Optimal Htc for Maximal Endurance Performance. Endurance per-
formance consists of the product of an individual's _VO2max and
duration of exercise at a certain percentage of that _VO2max until
exhaustion (21). Thus, to investigate the impact of varying Htc
levels on endurance performance, individual data of _VO2max
(Fig. 1) and time to exhaustion (Fig. 2) were plotted against Htc.
Time to exhaustion and _VO2max behaved as a polynomial sec-
ond-degree function in both wild-type and tg6 mice. As such,
greater changes in time to exhaustion and _VO2max were observed
at lower and higher Htc levels. Furthermore, time to exhaustion
was more sensitive to Htc alterations than _VO2max. Calculations
showed that greatest _VO2max and time to exhaustion values were
obtained at Htc values of 0.58 and 0.57 for wtNESP mice, re-
spectively, and 0.68 and 0.66 for tg6PHZ mice, respectively.
Effect of Varying Blood Volume, Total Hemoglobin Mass, and
Viscosity on Endurance Performance. Besides Htc, blood volume
and total hemoglobin mass play an important role in cardio-
vascular performance (2, 3, 22). To determine the blood volume
and total hemoglobin mass that are required to reach maximal
endurance performance, both parameters were correlated with
_VO2max. As shown in Fig. 3, when _VO2max of wtNESP and tg6PHZ
were expressed as a function of blood volume or total hemoglobin
mass, again a polynomial second-degree relation was observed.
The graphs illustrate that approximately twice as much blood
volume or total hemoglobin mass is necessary to reach maximal
_VO2max in tg6PHZ compared to the levels required in wtNESP.
Excessive erythrocytosis is known to impair blood ﬂow because
of anHtc-dependent elevation of blood viscosity, and consequently
less O2 is transported to the tissue (10). In turn, this reduces ex-
ercise capacity. We observed a correlation between _VO2max and
blood viscosity (Fig. 4). Compared to wtNESP, Epo-overexpressing
tg6 mice reached maximal _VO2max at a higher blood viscosity.
The association between blood viscosity and Htc in wild-type and
tg6 mice was similar with our previous ﬁndings (20).
Increasing Mean Arterial Blood Pressure, Constant Heart Rate, and
Altered Stroke Volume with Rising Htc Levels at _VO 2max. Mean
arterial blood pressure, heart rate, and stroke volume were all
quantiﬁed at _VO2max. Mean arterial blood pressure rose with
increasing Htc levels in wtNESP and tg6PHZ (Fig. S3 a).
Overall, wtNESP reached higher mean arterial blood pressure
values compared to those in tg6PHZ. Heart rate did not change
with increasing Htc levels and also was not different from group
to group (Fig. S3 b).
Previous studies have identiﬁed a correlation between stroke
volume and O2 pulse during exercise in humans (23, 24). Fig. S3 c
shows O2 pulse as a function of Htc at _VO2max. The O2 pulse of
wtNESP and tg6PHZ rises slightly with increasing Htc levels,
plateaus at respective maximum Htc values of 0.58 for wild-type
mice and 0.68 for tg6 mice, and then continues to decreases with
higher values. Fitted curves display polynomial second-degree
characteristics. In comparison with wtNESP, tg6PHZ showed a
greater impact of varying Htc levels on O2 pulse.
Increasing Myocardial _VO2 with Rising Htc Levels at _VO2max. To study
the impact of myocardial _VO2 on _VO2max, the rate pressure
product was also correlated with Htc levels. Myocardial _VO2
y = -252.78x 2 + 292.75x + 59.812 
R 2 = 0.7319; P < 0.0001 
y = -337.58x 2 + 461.8x - 14.515 
R 2 = 0.7771; P < 0.0001 
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increased with increasing Htc values in both groups (Fig. 5).
Both graphs showed a similar slope, but wtNESP mice had
higher rate pressure product values at corresponding Htc levels
than did tg6PHZ, indicating that the hearts of wtNESP mice had
a higher requirement of myocardial O2 supply.
Discussion
The present study demonstrates that optimal Htc values max-
imizing systemic endurance performance in mammals exist. In
doing so we observed that NESP-treated wild-type animals
maximized exercise performance at a lower optimal Htc than
hemolysed tg6PHZ mice constitutively overexpressing Epo.
Furthermore, the data demonstrated that (i) the optimal Htc
levels for maximal systemic exercise performance and maximal
stroke volume were similar; and (ii) blood volumes were dra-
matically increased at higher Htc levels.
_VO2max as well as time to exhaustion as well as initially rose,
reached a maximum value, and then decreased with increasing
Htc values. Maximal _VO2max and time to exhaustion values were
found at Htc levels of 0.58 and 0.57 for wtNESP, and 0.68 and
0.66 for tg6PHZ, respectively. Our data are in agreement with
the classical optimal Htc hypothesis (8, 10–12, 25), where it was
speculated that the optimal systemic Htc of mammals would be
much higher than the commonly observed 0.45. These calcu-
lations were based on the conditions present in the circulatory
system at rest, as exercise induces changes in vessel diameters,
blood ﬂow, internal temperature, and blood distribution. How-
ever, before this study there was no experimental proof of this
concept in living mammals. Gaethgens and coworkers (11)
studied the effect of blood perfusion creating various Htc levels
in isolated dog muscle during rhythmic isotonic exercise. Max-
imal _VO2 and contractile power reached a plateau at Htc levels
between 0.4 and 0.7. The authors concluded that these results
may not be transferable to whole-body systemic exercise because
each organ may present with its own individual optimal Htc (11,
16). Therefore, the systemic Htc value must be interpreted as an
average of all organ-speciﬁc optimal Htc values, thereby pro-
viding the whole organism with adequate O2 supply. During
exercise more O2 is required by the working skeletal muscles and
thus a shift from the optimal physiological to the optimal Htc
value for maximal endurance performance is observed. To cover
their high O2 demand during strenuous exercise, some terrestrial
vertebrate species, such as horses and dogs, but not mice, release
stored erythrocytes into the circulation by splenic contraction
(26, 27). This mechanism elevates the blood O2-carrying capacity
during exercise within seconds. As a consequence, Htc increases
from ≈0.4 at rest to ≈0.6 at exercise (28, 29) facilitating an im-
provement in exercise performance. These hematopoietic pa-
rameters return quickly to resting values when the animals stop
exercising, preventing a constant overload of the cardiovascular
system (28–30). In light of our data, it is tempting to speculate
that horses and dogs temporarily elevate their Htc levels close to
the optimal value Htc to reach maximal systemic endurance
performance. Indeed, splenic contraction has also been observed
in humans during performing a maximal exercise test, as evi-
denced by a reduction in its volume and two-thirds decrease in
splenic erythrocyte content, but Htc levels increased only a very
small percentage from rest to maximal working levels (31).
At ﬁrst glance, the observed relationship between _VO2max and
Htc in our study is in contradiction to others described in human
studies. Several investigators have shown that there is a strong
correlation between _VO2max and total hemoglobin mass or blood
volume (2, 3, 22), but not between _VO2max and Htc (32). It is of
note, however, that most human studies are carried out with Htc
levels between 0.4 and 0.5. Thus, the ergogenic effect of total
hemoglobin mass and blood volume as the primary limiting factors
of performance in endurance sports seems only to be valid in the
physiologically occurring Htc range. At higher Htc levels, other
y = -575.87x2 + 764.75x - 170.32
R2 = 0.7719; P < 0.0001
y = -1225.5x
2
+ 1389x - 298.72
R2 = 0.7691; P < 0.0001
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factors, such as blood viscosity, may counteract the positive effects
of enhanced arterialO2 content because the total hemoglobinmass,
unlike to Htc or [Hb], cannot be masked by other factors. In
agreement with this hypothesis, we found that the closest relation-
ship between _VO2max and total hemoglobin mass in wtNESP ani-
mals is within theHtc range of 0.4 and 0.55 (R2 = 0.513; P< 0.001).
The augmented blood volume at higher Htc values observed in
tg6 mice is caused by the dramatically increased number of
erythrocytes, whereas plasma volume remains unchanged (19).
An elevation in blood volume enhances end-diastolic volume
(preload) and results in increased stroke volume via the Starling
mechanism (33), which will lead to the enhancement of _VO2max
as long as heart rate is not altered. However, after reaching a
maximum of 0.57 for wtNESP and 0.68 for tg6PHZ, the blood
viscosity may have a negative contribution to cardiac perform-
ance. High blood viscosity increases arterial blood pressure and
diminishes venous return because of the increased peripheral
resistance (12, 34), a fact that may reduce stroke volume and
thus exercise performance. A converse observation is made in
patients suffering from polycythemic COPD after phlebotomy
(9). In these patients, an improvement in exercise tolerance
appears to be due to an improvement in cardiac function as
evidenced, primarily, by an increased stroke volume. The close
correlation between _VO2max and blood viscosity, as well as be-
tween stroke volume, arterial blood pressure, and Htc, conﬁrms
this explanation. Moreover, the fact that rate pressure product
and arterial blood pressures were increasing with incremental
elevation of Htc levels shows that _VO2max was unaffected by the
maximal work capacity of the heart at optimal Htc.
The different optimal Htc levels obtained by increasing the
normal physiological Htc of wild-type mice and reducing the
elevated Htc of tg6 mice could be resolved by at least two mech-
anisms: (i) enhancement of endothelial nitric oxide synthase ac-
tivity, which results in peripheral vasodilation despite concomitant
increased endothelial-1 levels (19, 35), and (ii) regulated elevation
of blood viscosity by increasing erythrocyte ﬂexibility in tg6 mice
compared to their controls (20). Both mechanisms would induce a
shift to a higher optimal Htc value in the tg6 mice. Thus, tg6PHZ
might be able to adapt better to varying Htc levels than wtNESP.
Physiological adaptations to excessive erythrocytosis are also ob-
served in dogs and humans (17, 18). Moreover, one case report in
sport medicine describes a successful Finnish cross-country skier
with an autosomal dominant mutation in Epo receptor that re-
sulted in increased sensitivity of erythroid progenitors to Epo that
ultimately led to Htc levels of 0.68 (17). That endurance athlete
won several Olympic gold medals. Based on our study, we con-
clude that his Htc may be very close to the optimal Htc for max-
imal endurance performance.
In summary, the results of the present study conﬁrm the optimal
Htc hypothesis during systemic exercise inmice. The reason for this
is that blood viscosity increases with rising Htc levels, limiting the
blood's O2 transport capacity. Furthermore, animals with chronic
excessive erythrocytosis adapted better to different Htc levels than
did acutely NESP-injected animals. At normoxia, the heart can
tolerate higher rate pressure product at higherHtc levels. Thus, the
optimal Htc values for maximal endurance performance were not
caused by heart failure or attainment of the maximal working ca-
pacity of the heart, _VO2max is mainly limited by O2 delivery.
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Materials and Methods
Experimental Animals and Set-up. The constitutively Epo-overexpressing tg6
mouse line was generated as described in ref. 19. Compared to wild-type
control, the tg6 mouse line had a 10- to 12-fold increase in plasma Epo-
levels, resulting in Htc levels of up to 0.9 (19, 20). Approximately half of the
offspring were hemizygous for the transgene and were used for the he-
molysis-inducing experiments, whereas the other half were used as wild type
for the hemoconcentration experiments. Males were 12 weeks old during
the ﬁrst exercise test (Table S1). In total, 41 wild-type mice and 40 tg6 mice
were analyzed. No weight loss occurred during the study period. Mice were
kept in standard rodent cages (T3) with food and water supplied ad libitum
in a 12 h/12 h light-dark cycle. The experimental protocols were approved by
the Kantonales Veterinäramt Zürich and were performed in accordance with
the Swiss animal protection laws and institutional guidelines.
The experimental design is shown in Fig. S4. At an age of 3 weeks, only tg6
mice were splenectomized to keep Htc levels low, because extramedullary
erythropoiesis occurs in the spleen (20). One week later, telemetric blood
pressure transmitters were implanted in 20 wild-type mice and 19 tg6 mice
that were 4 weeks old. In the remaining animals, dummy transmitters were
implanted (wild type, n = 21; tg6, n = 21). Adjustments of the Htc levels were
started in 8- and 9-week-old animals, respectively. At an age of 12 weeks,
the main experiments were conducted, including incremental as well as
constant workload exercise tests (see below) followed by measurements of
the SaO2, [Hb], Htc, blood viscosity, plasma, and blood volume. To exclude
the impact of circadian rhythm, all measurements were performed at the
identical time of day.
Other detailed methods are provided in SI Materials and Methods.
Statistics. All data were analyzed by using StatView software (Version 4.57;
Abacus Concepts). The relationship between the two parameters was ana-
lyzedwith linear or polynomial regression. Signiﬁcances were performed by a
one-way analysis of variance (ANOVA). Results are expressed as mean ± SD.
Statistical difference was set at P < 0.05.
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Fig. 5. Relationship between hematocrit (Htc) and rate pressure product pulse at maximal O2 uptake ( _VO2max) in wtNESP and tg6PHZ mice. Singles prints
represent individual values. —, regression plot of wild-type (wt)/wtNESP; —, regression plot of tg6/tg6PHZ.
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